Adrian Hayday

Adrian Hayday is Professor of Immunobiology and Kay Glendinning Professor at King's College London, pioneering research on gamma delta T cells since their discovery. His laboratory investigates unconventional T cell biology, tissue-specific immunity, and cancer immunotherapy applications.

Professor Hayday's foundational work established gamma delta T cells as key epithelial sentinels regulating tissue inflammation and carcinogenesis. Current research examines butyrophilin-mediated T cell selection in inflammatory bowel disease, tissue-adapted T cell states for cancer targeting, and immune mechanisms of post-COVID sequelae.

As co-lead of the NIHR Research Design Service London, he directs academic support for clinical research development. Translational initiatives include T cell therapy trials for hormone-refractory prostate cancer and novel immunotherapeutic approaches for head and neck carcinomas.